Technical / White Paper

Are there Any Markets left to Emerge?

Format: PDF file | Document type: Technical / White Paper | Promoted Content

This content is provided by World Courier, and any views and opinions expressed do not necessarily reflect those of www.outsourcing-pharma.com

Are there Any Markets left to Emerge?

North America, Western Europe and—to a lesser extent—Australasia once served as prime locations for the majority of research. But these Western markets are approaching saturation, which has led to a lack of naive patients who are available and willing to take part in trials.

Companies have thus turned to new global locations to run trials—an effort made far easier due to the huge improvements that emerging markets have made in investigator and patient identification, as well as regulatory initiatives.  Does it matter how far a country has emerged when selecting it as a study location?

Latest content from World Courier

show more

Risk Management in Global Pharmaceutical Logistics

Content provided by World Courier

Risk mitigation: mission critical

Pharmaceutical manufacturers need to understand and mitigate the risk in supply chain logistics. World Courier explore five rising trends impacting security of a product in transport.

Related resources from World Courier

Show more

Supplier info centre